Primary immunodeficiencies (PID) are a group of rare genetic disorders caused by defects in the immune system. These conditions result from inherited gene mutations that affect the immune system’s ability to function properly, leading to increased susceptibility to infections, autoimmune diseases, inflammatory disorders, and even certain types of cancer.
Unlike secondary immunodeficiencies, which develop due to external factors such as HIV infection, cancer, or immunosuppressive treatments, primary immunodeficiencies are congenital and often manifest in early childhood. However, some forms may remain undiagnosed until adulthood.
Treatment for PID varies depending on the specific type of immune system dysfunction and may include immunoglobulin replacement therapy, prophylactic antibiotics, bone marrow transplantation, or gene therapy.
F.A.Q. to the immunologist
Primary immunodeficiencies (PID) are considered rare diseases, but their overall prevalence is higher than previously thought. According to global estimates, PID affects approximately 1 in 1,000 to 1 in 5,000 people, depending on the specific type and region. However, some mild forms may go undiagnosed, meaning the actual number of affected individuals could be higher.
Certain types of PID, such as selective IgA deficiency, are relatively common, affecting about 1 in 300 to 1 in 500 people, while others, like severe combined immunodeficiency (SCID), are extremely rare, occurring in approximately 1 in 50,000 to 1 in 100,000 newborns.
Advancements in genetic testing and increased awareness have led to more frequent diagnoses, helping improve early detection and treatment for affected individuals.
The symptoms of primary immunodeficiencies (PID) vary depending on the specific type and severity of the disorder. However, common signs include:
Frequent and Severe Infections:
Recurrent respiratory infections (sinusitis, bronchitis, pneumonia)
Persistent ear infections (otitis media)
Skin infections, abscesses, or slow-healing wounds
Gastrointestinal infections, chronic diarrhea, or malabsorption
Unusual or severe viral, bacterial, fungal, or parasitic infections
Autoimmune and Inflammatory Symptoms:
Chronic inflammation of the lungs, intestines, or joints
Autoimmune disorders (e.g., lupus, rheumatoid arthritis, autoimmune cytopenias)
Skin conditions such as eczema, psoriasis, or chronic rashes
Delayed Growth and Development:
Poor weight gain or growth failure in children
Developmental delays due to chronic illness
Other Signs:
Swollen lymph nodes or an enlarged spleen
Low blood cell counts (anemia, neutropenia, thrombocytopenia)
High susceptibility to certain cancers
If someone experiences frequent or severe infections, unexplained immune-related symptoms, or a family history of immunodeficiency, medical evaluation and genetic testing may be necessary for diagnosis. Early detection can help manage the condition effectively.
There are over 450 types of primary immunodeficiencies (PID), but some are more frequently diagnosed than others. The most common types include:
1. Selective IgA Deficiency
Prevalence: 1 in 300 to 1 in 500 people (most common PID)
Description: A lack of immunoglobulin A (IgA), which plays a key role in mucosal immunity (e.g., respiratory and gastrointestinal tracts).
Symptoms: Many individuals have no symptoms, but others may experience recurrent infections, allergies, or autoimmune diseases.
2. Common Variable Immunodeficiency (CVID)
Prevalence: 1 in 25,000 to 1 in 50,000 people
Description: A group of disorders characterized by low levels of antibodies (IgG, IgA, and/or IgM), leading to increased susceptibility to infections.
Symptoms: Frequent respiratory infections, autoimmune diseases, and a higher risk of gastrointestinal and lung diseases.
3. X-Linked Agammaglobulinemia (XLA, or Bruton’s Disease)
Prevalence: 1 in 200,000 males
Description: A genetic disorder (affecting males) that results in an absence of B cells, leading to very low antibody levels.
Symptoms: Severe bacterial infections, chronic lung disease, and poor response to vaccines.
4. Severe Combined Immunodeficiency (SCID)
Prevalence: 1 in 50,000 to 1 in 100,000 newborns
Description: A group of life-threatening disorders in which both T and B cells are defective or absent, making the immune system nonfunctional.
Symptoms: Severe infections in infancy, failure to thrive, and life-threatening complications without early treatment (such as bone marrow transplant).
5. Chronic Granulomatous Disease (CGD)
Prevalence: 1 in 200,000 people
Description: A genetic disorder affecting white blood cells, making it difficult to kill certain bacteria and fungi.
Symptoms: Recurrent skin and lung infections, abscesses, and chronic inflammation.
6. Hyper-IgE Syndrome (Job’s Syndrome)
Prevalence: Very rare (1 in 100,000 to 1 in 1,000,000 people)
Description: A disorder characterized by high levels of IgE antibodies and susceptibility to infections.
Symptoms: Recurrent skin and lung infections, eczema, bone abnormalities, and dental problems.
Many primary immunodeficiencies vary in severity, and some individuals may go undiagnosed for years. Improved genetic testing and awareness have helped in identifying and managing these conditions more effectively.
In addition to frequent and severe infections, primary immunodeficiencies (PID) can cause a range of other symptoms affecting different body systems. These additional symptoms include:
1. Autoimmune and Inflammatory Symptoms:
Chronic inflammation (lungs, intestines, joints)
Autoimmune diseases (e.g., lupus, rheumatoid arthritis, autoimmune cytopenias)
Chronic skin conditions (eczema, psoriasis, persistent rashes)
Vasculitis (inflammation of blood vessels)
2. Gastrointestinal Issues:
Chronic diarrhea or malabsorption
Frequent bloating, nausea, or stomach pain
Inflammatory bowel disease (IBD)-like symptoms
Liver abnormalities or enlarged liver
3. Growth and Development Problems:
Failure to thrive (poor weight gain in infants and children)
Delayed puberty or slow growth
Developmental delays due to chronic illness
4. Blood and Lymphatic System Abnormalities:
Low blood cell counts (anemia, neutropenia, thrombocytopenia)
Swollen lymph nodes or an enlarged spleen
Increased risk of lymphoma or other blood cancers
5. Respiratory and Lung Complications:
Chronic cough or wheezing
Structural lung damage (bronchiectasis)
Frequent sinus infections or chronic sinusitis
6. Neurological and Behavioral Symptoms:
Chronic fatigue and weakness
Migraines or unexplained headaches
Neuropathy (nerve damage)
Increased risk of depression and anxiety due to chronic illness
7. Increased Risk of Cancer:
Higher susceptibility to lymphoma, leukemia, or other cancers
Chronic viral infections that may increase cancer risk
These symptoms vary depending on the type of PID and the severity of immune dysfunction. If someone has multiple unexplained health issues, especially frequent infections combined with autoimmune or inflammatory symptoms, they should seek medical evaluation for possible immunodeficiency.
Primary immunodeficiencies (PID) are diagnosed through:
Medical History & Physical Exam – Evaluating recurrent infections, autoimmune conditions, and family history.
Blood Tests – Checking white blood cells, immunoglobulin levels (IgG, IgA, IgM), and specific antibody responses.
Functional Immune Tests – Assessing T-cell, B-cell, and neutrophil function.
Genetic Testing – Identifying gene mutations linked to PID.
Newborn Screening – Detecting severe PIDs like SCID at birth.
Early diagnosis is key to effective treatment and management.
People with PID are prone to frequent, severe, and persistent infections, including:
Respiratory infections – Pneumonia, bronchitis, sinusitis, and chronic cough.
Ear infections – Recurrent otitis media (middle ear infections).
Skin infections – Abscesses, boils, fungal infections, and slow-healing wounds.
Gastrointestinal infections – Chronic diarrhea, bacterial overgrowth, and persistent stomach issues.
Fungal and viral infections – Candida (yeast infections), herpes, warts, and severe viral illnesses.
Unusual or opportunistic infections – Rare bacterial or fungal infections that healthy individuals typically resist.
These infections may be recurrent, hard to treat, and require prolonged antibiotics or specialized care.
Treatment for PID depends on the specific type and severity but may include:
Immunoglobulin (Ig) Therapy – Regular IV or subcutaneous infusions to replace missing antibodies.
Antibiotics & Antifungals – Long-term or preventive use to manage recurrent infections.
Bone Marrow or Stem Cell Transplant – A potential cure for severe cases like SCID.
Gene Therapy – Experimental but promising for certain genetic PIDs.
Cytokine or Enzyme Therapy – Used in some immune system disorders.
Lifestyle & Supportive Care – Vaccinations (excluding live vaccines), proper nutrition, and infection prevention strategies.
Early diagnosis and appropriate treatment help improve quality of life and reduce complications.
Some severe PIDs can be cured, while others require lifelong management:
Curable: Bone marrow/stem cell transplant or gene therapy can potentially cure conditions like SCID.
Manageable: Most PIDs, such as CVID or IgA deficiency, require ongoing immunoglobulin therapy, antibiotics, and infection prevention.
Early diagnosis and proper treatment significantly improve quality of life and life expectancy.
PID can impact daily life in several ways:
Frequent infections – Leading to missed work, school, and social activities.
Chronic fatigue – Due to ongoing illness and immune dysfunction.
Long-term treatments – Regular immunoglobulin infusions, antibiotics, or hospital visits.
Lifestyle adjustments – Avoiding crowded places, maintaining hygiene, and dietary changes.
Emotional impact – Anxiety or stress from health uncertainties.
With proper management, many individuals with PID can lead active and fulfilling lives.
Genetic counseling is essential for individuals and families affected by PID. It helps:
Identify inherited risks – Determines the likelihood of passing PID to children.
Guide genetic testing – Helps diagnose specific PID types.
Support family planning – Provides options like prenatal testing or IVF with genetic screening.
Offer personalized care – Helps tailor treatment based on genetic findings.
Genetic counseling empowers families with knowledge for better decision-making and management.
PIDs can be inherited in several ways:
X-linked recessive – Affects mostly males (e.g., X-linked agammaglobulinemia, CGD).
Autosomal recessive – Both parents must carry the gene (e.g., SCID, some forms of CGD).
Autosomal dominant – One mutated gene from either parent is enough (e.g., some CVID cases).
De novo mutations – Occur spontaneously without family history.
In autosomal recessive inheritance, a person must inherit two mutated copies of a gene (one from each parent) to develop PID. Key points:
Carriers (one mutated gene) usually have no symptoms.
Affected individuals (two mutated genes) experience immune system dysfunction.
Each child of carrier parents has a:
- 25% chance of having PID.
- 50% chance of being a carrier.
- 25% chance of inheriting normal genes.
This pattern is seen in SCID, certain CGD types, and other PIDs. Genetic counseling helps assess family risks.
In X-linked recessive inheritance, the mutated gene is on the X chromosome, affecting mostly males, since they have only one X chromosome. Key points:
- Males with the mutation develop PID.
- Females with one mutated gene are usually carriers but may have mild symptoms.
- Carrier mothers have a 50% chance of passing the mutation to sons (who will be affected) and 50% chance of passing it to daughters (who will be carriers).
Common X-linked PIDs include X-linked agammaglobulinemia (XLA) and chronic granulomatous disease (CGD). Genetic counseling is important for family planning.
Autoinflammatory diseases result from innate immune system dysregulation. Common examples include:
- Familial Mediterranean Fever (FMF) – Recurrent fevers, abdominal pain, joint inflammation.
- Cryopyrin-Associated Periodic Syndromes (CAPS) – Includes conditions like Muckle-Wells Syndrome, causing fevers, rashes, and joint pain.
- TNF Receptor-Associated Periodic Syndrome (TRAPS) – Fever episodes, muscle pain, and rashes.
- Hyper-IgD Syndrome (HIDS) – Recurrent fevers, swollen lymph nodes, and abdominal pain.
- Blau Syndrome – Granulomatous inflammation affecting the skin, joints, and eyes.
These conditions are often genetic and treated with anti-inflammatory or biologic therapies.
No, PID and AIDS are different conditions:
PID (Primary Immunodeficiency):
-
- Genetic (inherited) disorders causing immune system dysfunction.
- Present from birth, can affect children and adults.
- Examples: SCID, CVID, XLA.
-
AIDS (Acquired Immunodeficiency Syndrome):
- Caused by HIV infection, not inherited.
- Develops over time as HIV weakens the immune system.
- Can be prevented and managed with antiviral therapy.
Both involve immune dysfunction but have different causes, progression, and treatments.
Neonatal screening is a routine medical test for newborns to detect serious genetic, metabolic, and immune disorders early.
Key Features:
- Done within the first days of life using a heel-prick blood sample.
- Identifies conditions like SCID (severe combined immunodeficiency), metabolic disorders, and hormone deficiencies.
- Allows for early treatment, preventing severe complications or death.
Neonatal screening is crucial for early diagnosis and improving health outcomes.
Yes, since October 17, 2022, Ukraine has implemented an expanded neonatal screening program, which includes testing for severe combined immunodeficiency (SCID)—a life-threatening primary immunodeficiency.
Early detection through this screening allows for timely treatment, such as bone marrow transplantation, improving survival and quality of life for affected infants.
Yes, several European countries have implemented neonatal screening programs for severe combined immunodeficiency (SCID), a severe form of PID. Norway was the first European country to introduce nationwide SCID screening in January 2018. Additionally, regions like Catalonia in Spain started universal SCID screening in January 2017. Other countries, such as Sweden, Germany, the UK, and France, have initiated pilot programs or are in the process of integrating SCID screening into their national newborn screening protocols. However, the availability and extent of these screenings vary across Europe, with some countries yet to implement such programs.
Yes, certain primary immunodeficiencies (PIDs) are more frequently observed in Ukraine, notably:
-
Nijmegen Breakage Syndrome (NBS): A DNA repair disorder leading to microcephaly, growth retardation, immunodeficiency, and increased cancer risk.
-
Ataxia-Telangiectasia (AT): Characterized by progressive neurological impairment, immunodeficiency, and a higher likelihood of malignancies.
-
DiGeorge Syndrome (DGS): Results from a chromosomal deletion causing heart defects, cleft palate, distinctive facial features, and variable immunodeficiency.
These PIDs are more prevalent in Ukraine due to specific genetic factors within the population. Recognizing the clinical signs of these syndromes is crucial for early diagnosis and appropriate management.
Yes, certain primary immunodeficiencies (PIDs) are more frequently diagnosed in Europe, notably:
-
Common Variable Immunodeficiency (CVID): CVID is one of the most prevalent PIDs worldwide, including Europe. It is characterized by low levels of serum immunoglobulins and an increased susceptibility to infections.
-
Selective IgA Deficiency: This is the most common primary immunodeficiency, particularly among individuals of European descent. It involves a lack of immunoglobulin A (IgA), leading to increased vulnerability to infections.
The higher prevalence of these PIDs in Europe may be attributed to genetic factors and improved diagnostic capabilities in the region.
